Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment. [electronic resource]
Producer: 20170425Description: 677-683 p. digitalISSN:- 1479-683X
- Aged
- Aged, 80 and over
- Bone Density Conservation Agents -- therapeutic use
- Bone Remodeling -- genetics
- Case-Control Studies
- Cathepsin K -- genetics
- Collagen Type I -- metabolism
- Denosumab -- therapeutic use
- Deprescriptions
- Down-Regulation
- Female
- Gene Expression Regulation
- Humans
- MicroRNAs -- metabolism
- Middle Aged
- Osteogenesis -- genetics
- Osteoporosis, Postmenopausal -- drug therapy
- Osteoporotic Fractures -- genetics
- Peptide Fragments -- metabolism
- Peptides -- metabolism
- Procollagen -- metabolism
- RNA, Messenger -- metabolism
- Receptor Activator of Nuclear Factor-kappa B -- genetics
- Spinal Fractures -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.